Skip to content

Haleon

US · HLN #553 by market cap Listed 2022
9.07 +0.02 +0.22%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:59

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 15 in the most recent period (2026/Q4).
  • Total institutional ownership fell 0.1 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
95.33% -0.15pp
Institutions
1,071 -15
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund81.48%
Private Company3.80%
Sovereign Wealth Fund3.78%
Public Company2.57%
Government Pension Fund1.51%
Hedge Fund1.28%
VC/PE Fund0.43%
Government0.16%
Insurance Company0.15%
Other4.83%

Top holders as of 2026-09-30

BlackRock 8.76% · 385.24M sh
Dodge & Cox 5.76% · 253.38M sh
MFS Investment Management 4.06% · 178.53M sh
Vanguard Capital Management, LLC 3.93% · 172.96M sh
First Eagle Investment Management, LLC 2.71% · 119.12M sh
Schroder Investment Management Limited 2.46% · 108.27M sh
Wellington Management Group 2.19% · 96.43M sh
Principal Global Investors, LLC 2.03% · 89.28M sh
Amundi Asset Management 1.90% · 83.50M sh
Norges Bank Investment Management 1.87% · 82.16M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

2 filings tracked · 0 buys · 2 sells

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2023-12-26 Glaxosmithkline (Us) Trust -- Intent to Sell (Form 144) -8,527,104 $8.28
2023-12-04 Gsk Master Grantor Trust -- Intent to Sell (Form 144) -404,599 $8.57
2023-11-05 GlaxoSmithKline Employee Trust -- Intent to Sell (Form 144) -173,611 $7.96

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:59:23 · For reference only, not investment advice and not tailored to your situation.

Haleon discussion 0 comments

Add a comment